drug protocol number

EPO-TRAUMA ANZIC-RC/CF001 - CT20/046/R

drug sponsor

KAIMRC/Australian and New Zealand Intensive Care Research Centre

drug study

Epoetin Alfa (Recombinant Human Erythropoietine) (EPREX)

drug trial site

King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase